Icon
+91 94997 68112
Login Register

VYKOURA - (EQ 50MG BASE/5ML (EQ 10MG BASE/ML), EQ 350MG BASE/35ML (EQ 10MG BASE/ML), EQ 500MG BASE/50ML (EQ 10MG BASE/ML); SOLUTION)

LEUCOVORIN CALCIUM None
EQ 50MG BASE/5ML (EQ 10MG BASE/ML), EQ 350MG BASE/35ML (EQ 10MG BASE/ML), EQ 500MG BASE/50ML (EQ 10MG BASE/ML); SOLUTION
Less Than $1000 mn
None None
None None
None None
VYKOURA is a folate analog indicated for: • Rescue after high-dose methotrexate therapy in adult and pediatric patients. • Reducing the toxicity of o methotrexate in adult and pediatric patients with impaired methotrexate elimination or o folic acid antagonists or dihydrofolate reductase (DHFR) inhibitors following an overdose in adult and pediatric patients.• Treatment of megaloblastic anemias due to folic acid deficiency in adult and pediatric patients when oral therapy is not feasible. • Treatment of patients with metastatic colorectal cancer in combination with 5-fluorouracil.
Yes
VYKOURA Patent 1
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.